相似文献
1
Medulloblastoma: novel insights into emerging therapeutic targets.
Expert Opin Ther Targets. 2021 Aug;25(8):615-619. doi: 10.1080/14728222.2021.1982896. Epub 2021 Oct 4.
2
Hitting the target in medulloblastoma therapy.
Drug Discov Today. 2004 Dec 1;9(23):994-5. doi: 10.1016/S1359-6446(04)03289-1.
3
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
N Engl J Med. 2009 Sep 17;361(12):1173-8. doi: 10.1056/NEJMoa0902903. Epub 2009 Sep 2.
4
Challenges and Recent Advances of Novel Chemical Inhibitors in Medulloblastoma Therapy.
Methods Mol Biol. 2022;2423:123-140. doi: 10.1007/978-1-0716-1952-0_13.
5
HDAC inhibitors to the rescue in sonic hedgehog medulloblastoma.
Neuro Oncol. 2019 Sep 6;21(9):1091-1092. doi: 10.1093/neuonc/noz115.
6
Blood-Brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of Medulloblastoma.
Cancer Cell. 2016 Apr 11;29(4):427-429. doi: 10.1016/j.ccell.2016.03.024.
7
Medulloblastoma: signalling a change in treatment.
Lancet Oncol. 2004 Apr;5(4):209-18. doi: 10.1016/S1470-2045(04)01424-X.
8
SHH inhibitors for the treatment of medulloblastoma.
Expert Rev Neurother. 2015;15(7):763-70. doi: 10.1586/14737175.2015.1052796. Epub 2015 May 31.
9
Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma.
Neuro Oncol. 2022 Jul 1;24(7):1210-1211. doi: 10.1093/neuonc/noac061.
10
Medulloblastoma growth inhibition by hedgehog pathway blockade.
Science. 2002 Aug 30;297(5586):1559-61. doi: 10.1126/science.1073733.
引用本文的文献
1
Therapeutic approaches for targeting the pediatric brain tumor microenvironment.
Drug Deliv Transl Res. 2025 Apr 21. doi: 10.1007/s13346-025-01839-3.
2
Functional MRI Assessment of Brain Activity Patterns Associated with Reading in Medulloblastoma Survivors.
Brain Sci. 2024 Sep 6;14(9):904. doi: 10.3390/brainsci14090904.
3
Angiogenesis and Lymphangiogenesis in Medulloblastoma Development.
Biology (Basel). 2023 Jul 21;12(7):1028. doi: 10.3390/biology12071028.
4
Ligand Installation to Polymeric Micelles for Pediatric Brain Tumor Targeting.
Polymers (Basel). 2023 Apr 6;15(7):1808. doi: 10.3390/polym15071808.
本文引用的文献
1
Tumor Vessels Fuel the Fire in Glioblastoma.
Int J Mol Sci. 2021 Jun 17;22(12):6514. doi: 10.3390/ijms22126514.
2
Vascular normalisation as the stepping stone into tumour microenvironment transformation.
Br J Cancer. 2021 Aug;125(3):324-336. doi: 10.1038/s41416-021-01330-z. Epub 2021 Apr 7.
3
Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.
Neurooncol Adv. 2021 Feb 18;3(1):vdab002. doi: 10.1093/noajnl/vdab002. eCollection 2021 Jan-Dec.
4
REST promotes ETS1-dependent vascular growth in medulloblastoma.
Mol Oncol. 2021 May;15(5):1486-1506. doi: 10.1002/1878-0261.12903. Epub 2021 Feb 7.
5
Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier.
Neuro Oncol. 2021 May 5;23(5):732-742. doi: 10.1093/neuonc/noaa266.
6
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Mol Neurobiol. 2020 May;57(5):2461-2478. doi: 10.1007/s12035-020-01892-8. Epub 2020 Mar 9.
7
Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients.
Nat Commun. 2020 Feb 17;11(1):929. doi: 10.1038/s41467-020-14700-7.
8
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Nat Rev Cancer. 2020 Jan;20(1):26-41. doi: 10.1038/s41568-019-0205-x. Epub 2019 Oct 10.
9
c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.
Cells. 2019 May 23;8(5):498. doi: 10.3390/cells8050498.
10
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas.
J Hematol Oncol. 2019 Mar 15;12(1):29. doi: 10.1186/s13045-019-0712-y.
Zotero 插件